Baidu
map

江西部署2018年中医药重点工作,启动中医药人才培养"杏林计划"

2018-02-02 周翔 中国中医

1月29日,江西中医药工作会议暨中医药人才培养“杏林计划”启动会在南昌召开。江西省卫生计生委副主任程关华对2018年全省中医药重点工作进行部署。

1月29日,江西中医药工作会议暨中医药人才培养“杏林计划”启动会在南昌召开。江西省卫生计生委副主任程关华对2018年全省中医药重点工作进行部署。

会议指出,江西中医药工作要坚持新发展理念,在新的历史方位下谋划中医药发展任务和路径。一要做优中医药服务,实施国家中医药综合改革试验区建设行动计划,协调推进公立中医医院综合改革,实施全国社会办中医试点。进一步提升中医服务能力,稳步推进江西省中医医疗集团建设,筹建全省中药院内制剂中心,继续推进江西省中医康复“热敏灸”联盟建设和中医骨伤专科联盟建设。二要做强中医药产业,加快建设中医药强省,大力推进中医药科创城、上饶中医药健康旅游示范区建设,支持樟树打造“中国药都”,支持“盱江医学”、南城“建昌邦”振兴发展,主动融入中医药产业强省大局。三要做大中医药种植,重点推进第四次中药资源普查和良种繁育、种植基地建设。注重用好普查成果,把数据做实、把资源摸清,为实施森林药材产业工程和中药材产业发展工程提供必要的参考,为各地中药材产业发展规划实施提供必要的支撑。四要做活中医药创新,加快实施中医药标准化项目。加快推进江西中医药大学附属医院、九江市中医院和南昌市洪都中医院国家中医药传承创新工程项目建设。五要做靓中医药品牌,继续加快实施中医中药中国行——江西省中医药健康文化推进行动,推进中医药文化进校园。探索打造“国医大师论道”论坛。围绕实施健康中国战略,立足江西,辐射全国,面向全球,搭建新型中医药高端对话与交流平台,创新大健康文化传播形式,传播大健康理念与文化,助力中医药健康事业和健康产业融合发展。

会议通报了2017年江西省中医药人才工作所取得的优秀成果,同期启动中医药人才培养“杏林计划”,拟用10年左右时间,力争实现“5个5”的中医药人才培养目标,即培养或引进5名以上国家级中医药杰出人才;培养50名以上中医药领军人才;培养500名以上高层次人才;培养500名以上中西医结合人才;培养500名以上基层中医药优秀人才,形成一支支撑江西中医药事业发展的高层次人才队伍。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1945501, encodeId=cf6b194550189, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Apr 12 08:49:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796811, encodeId=d7eb1e9681198, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 12:49:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796799, encodeId=d79b1e96799b6, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Mon Nov 12 21:49:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409338, encodeId=40d614093389a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469588, encodeId=09ea146958882, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554880, encodeId=928a155488080, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284533, encodeId=93a22845335a, content=为祖国医药培养人才!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A7970DEFB5308BB639E9D3A10B51A889/100, createdBy=1c772233501, createdName=Doctor Peng, createdTime=Fri Feb 02 21:08:13 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1945501, encodeId=cf6b194550189, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Apr 12 08:49:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796811, encodeId=d7eb1e9681198, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 12:49:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796799, encodeId=d79b1e96799b6, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Mon Nov 12 21:49:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409338, encodeId=40d614093389a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469588, encodeId=09ea146958882, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554880, encodeId=928a155488080, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284533, encodeId=93a22845335a, content=为祖国医药培养人才!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A7970DEFB5308BB639E9D3A10B51A889/100, createdBy=1c772233501, createdName=Doctor Peng, createdTime=Fri Feb 02 21:08:13 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1945501, encodeId=cf6b194550189, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Apr 12 08:49:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796811, encodeId=d7eb1e9681198, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 12:49:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796799, encodeId=d79b1e96799b6, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Mon Nov 12 21:49:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409338, encodeId=40d614093389a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469588, encodeId=09ea146958882, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554880, encodeId=928a155488080, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284533, encodeId=93a22845335a, content=为祖国医药培养人才!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A7970DEFB5308BB639E9D3A10B51A889/100, createdBy=1c772233501, createdName=Doctor Peng, createdTime=Fri Feb 02 21:08:13 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1945501, encodeId=cf6b194550189, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Apr 12 08:49:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796811, encodeId=d7eb1e9681198, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 12:49:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796799, encodeId=d79b1e96799b6, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Mon Nov 12 21:49:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409338, encodeId=40d614093389a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469588, encodeId=09ea146958882, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554880, encodeId=928a155488080, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284533, encodeId=93a22845335a, content=为祖国医药培养人才!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A7970DEFB5308BB639E9D3A10B51A889/100, createdBy=1c772233501, createdName=Doctor Peng, createdTime=Fri Feb 02 21:08:13 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
    2018-02-04 hb2008ye
  5. [GetPortalCommentsPageByObjectIdResponse(id=1945501, encodeId=cf6b194550189, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Apr 12 08:49:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796811, encodeId=d7eb1e9681198, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 12:49:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796799, encodeId=d79b1e96799b6, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Mon Nov 12 21:49:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409338, encodeId=40d614093389a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469588, encodeId=09ea146958882, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554880, encodeId=928a155488080, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284533, encodeId=93a22845335a, content=为祖国医药培养人才!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A7970DEFB5308BB639E9D3A10B51A889/100, createdBy=1c772233501, createdName=Doctor Peng, createdTime=Fri Feb 02 21:08:13 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1945501, encodeId=cf6b194550189, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Apr 12 08:49:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796811, encodeId=d7eb1e9681198, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 12:49:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796799, encodeId=d79b1e96799b6, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Mon Nov 12 21:49:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409338, encodeId=40d614093389a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469588, encodeId=09ea146958882, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554880, encodeId=928a155488080, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284533, encodeId=93a22845335a, content=为祖国医药培养人才!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A7970DEFB5308BB639E9D3A10B51A889/100, createdBy=1c772233501, createdName=Doctor Peng, createdTime=Fri Feb 02 21:08:13 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1945501, encodeId=cf6b194550189, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Apr 12 08:49:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796811, encodeId=d7eb1e9681198, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 12:49:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796799, encodeId=d79b1e96799b6, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Mon Nov 12 21:49:00 CST 2018, time=2018-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409338, encodeId=40d614093389a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469588, encodeId=09ea146958882, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554880, encodeId=928a155488080, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sun Feb 04 09:49:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284533, encodeId=93a22845335a, content=为祖国医药培养人才!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A7970DEFB5308BB639E9D3A10B51A889/100, createdBy=1c772233501, createdName=Doctor Peng, createdTime=Fri Feb 02 21:08:13 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
    2018-02-02 Doctor Peng

    为祖国医药培养人才!

    0

相关资讯

江西省出台《关于深化职称制度改革的实施意见》

“我能评到正高,要感谢职称制度改革。”江西凯顺科技有限公司董事长包健说。2016年以前,虽然获得江西省技术发明奖二等奖,但包健无任何职称。职称制度改革后,非公有制经济组织、社会组织、自由职业专业技术人才可以进行职称申报,一大批人才因此受益。12月11日,记者从省政府新闻办、省人社厅联合举办的新闻发布会上获悉,我省《关于深化职称制度改革的实施意见》(以下简称《意见》)正式出台,这是我省实行专业技术职

重磅!职称制度迎来重大改革

江西实行专业技术职务聘任制度30年来首次重大改革,备受关注!

江西改善就医体验 医疗纠纷数3年降4成

11月27日,江西省“改善群众就医体验”三年行动新闻发布会在南昌召开。 吴鹏泉/摄针对医疗服务中的热点难点问题,江西省于2014年10月组织开展了“改善群众就医体验”主题活动,与2015年启动的“进一步改善医疗服务行动计划”目标一致、内容相近。据了解,江西在梳理近年来群众反应强烈、投诉较多问题的基础上,提出“强化四项管理、改善四种体验”(即强化服务流程管理,改善就医等待体验;强化诊疗服务管理,改善

江西部分地市可提供“空中120”救援

航空医疗急救(空中120)是对地面医疗救援的有效补充。南昌市首架120空中救援直升机日前在洪都中医院进行了首次空中救援演练和培训。今后,如遇紧急救援情况,南昌市民或周边县市转院至南昌医院的危重患者都可呼叫“空中120”。据了解,这台120空中救援直升机舱内配有除颤监护仪、呼吸机等设备,驾驶舱可容纳2名飞行员,机舱可同时容纳1名患者和2名医护人员。当突发事故或疾病导致病情危重,如车祸创伤、休克、急性

江西医改大动作!公立医院全部取消药品加成

刚刚公布!重大利好!9月9日起江西省公立医院综合改革实现全覆盖9月底,全省所有公立医院全部取消药品加成(中药饮片除外)、挂号费并入诊查费……

江西:省直医院政策性亏损财政兜底

9月9日零时起,江西省南昌市、吉安市公立医院和江西省直医院启动以取消药品加成为标志的公立医院综合改革,持续多年的以药补医在江西彻底终结。

Baidu
map
Baidu
map
Baidu
map